Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immunogenetics of glioblastoma: the future of personalized patient management

28 Nov 2018

Abstract excerpt

The prognosis of glioblastoma has changed little over the past two decades, with only minor improvements in length of overall survival through the addition of temozolomide (temodal) to standard of care and the recommended use of alternating electric field therapy (optune) to newly diagnosed patients. In an effort to define novel therapeutic targets across molecularly heterogeneous disease subgroups, researchers...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Glioma Diagnosis and Treatment
Share to Immune cells in cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30534602
DOI: 10.1038/s41698-018-0070-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immunogenetics of glioblastoma: the future of personalized patient managementPMID 30534602Read ↗

Glioblastoma update: molecular biology, diagnosis, treatment, response assessment, and translational clinical trialsSemantic proximity Read ↗

Molecular biology of the deadliest cancer – glioblastoma: what do we know?Semantic proximity Read ↗

Deciphering Glioblastoma: Fundamental and Novel Insights into the Biology and Therapeutic Strategies of GliomasSemantic proximity Read ↗

Immunophenotypic Profile of Adult Glioblastoma IDH-Wildtype Microenvironment: A Cohort StudySemantic proximity Read ↗

Molecular Heterogeneity and Immunosuppressive Microenvironment in GlioblastomaSemantic proximity Read ↗

Tumor antigens and immune subtypes of glioblastoma: the fundamentals of mRNA vaccine and individualized immunotherapy developmentSemantic proximity Read ↗

Personalized Medicine for GliomasSemantic proximity Read ↗

Tumoral and immune heterogeneity in an anti-PD-1-responsive glioblastoma: a case study.Semantic proximity Read ↗

Immune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies.Semantic proximity Read ↗

Understanding the Genomic Landscape of Glioblastoma: Opportunities for Targeted TherapiesSemantic proximity Read ↗

Improved prognostication of glioblastoma beyond molecular subtyping by transcriptional profiling of the tumor microenvironmentSemantic proximity Read ↗

Potential of IDH mutations as immunotherapeutic targets in gliomas: a review and meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.